6533b872fe1ef96bd12d43d2

RESEARCH PRODUCT

Weight response to GLP-1 receptor agonists: Why women do it better?

Mojca JensterleManfredi RizzoAndrej Janež

subject

diabetes obesityDipeptidyl-Peptidase IV InhibitorsEndocrinologyDiabetes Mellitus Type 2Endocrinology Diabetes and MetabolismInternal MedicineHumansHypoglycemic AgentsFemaleGlucagon-Like Peptide-1 Receptor

description

nessuno

10.1016/j.jdiacomp.2022.108310https://pubmed.ncbi.nlm.nih.gov/36150366